Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
Clinical trial NCT06101342 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06101342
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2026-07-27
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.